EISENBERG JEFFREY F 4
4 · Xenetic Biosciences, Inc. · Filed Dec 13, 2023
Insider Transaction Report
Form 4
EISENBERG JEFFREY F
Director
Transactions
- Award
Stock Options
2023-12-11+20,000→ 20,000 totalExercise: $3.88Exp: 2033-12-11→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026.